PracticeUpdate Conference Series World Congress of Dermatology 2019

© WCD 2019

CONTENTS WCD 2019 • 10–15 June 2019 • Milan, Italy BY THE PRACTICEUPDATE EDITORIAL TEAM

3

4

14

3 Expert Outlines Nonsurgical Options for Diffuse Epidermal Field Cancerization 4 Role of Gut/Cutaneous Dysbiosis in Dermatological Disease Highlighted 5 In-Vivo Confocal Microscopy Offers Diagnostic Benefits For Suspected Melanoma 6 Psoriatic Arthritis Expert Implores Dermatologists to Become More Involved in This Condition 8 Two-Year Study Confirms Long-Term Benefits of Risankizumab in Psoriasis 9 Oral Baricitinib Relieved Symptoms of Atopic Dermatitis In Two Phase III Trials

10 Perils of Private-Equity Dermatology Practices Many and Far-Reaching 12 Treatment History May Affect Effectiveness of Some Systemic Therapies for Psoriasis 12 Topical Ruxolitinib Shows Promise in Relieving Vitiligo Lesions 14 Experimental Topical Tropomyosin Receptor Kinase A Inhibitor Improved Psoriasis Severity 15 Extracorporeal Photopheresis With 5-Aminolevulinic Acid Proves Safe in Early Pilot Study

16 Real-World Data Demonstrate 17 Dupilumab Offers Clinically Meaningful Benefit for Adolescent Atopic Dermatitis 18 Xolma Study Suggests Omalizumab May Play Role in Treatment of Cutaneous Mastocytosis 19 Systemic Psoriasis Treatments Equally Effective in Older and Younger Patients 20 Guselkumab Durably Effective in Psoriasis Patients After 3-Year Follow-Up Apremilast Reduces Psoriasis Disease Severity

The production of this publication is sponsored by Sun Pharma ANZ. The provision of this information is not intended to advocate any use not covered by the Product Information. Please check that the product is approved for use and always consult the Product Information before prescribing.

1

WCD 2019 • PRACTICEUPDATE CONFERENCE SERIES